U.S. Disinfecting Cap Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

U.S. Disinfecting Cap Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
SEATTLE - Sept. 10, 2020 - PRLog -- U.S. Disinfecting Cap Market, by Application (Central Venous Line, Peripheral IV Catheters and Others), and by End User (Hospital and Clinics, Ambulatory/Outpatient Surgical Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

According to a study done by researchers from the Mercy Hospital in St. Louis, published in the Journal of the Association for Vascular Access 2017, the rate of peripheral venous catheter-related bloodstream infections decreased from 0.57 to 0.11 per 1,000 patients in a day, with the use of the PIV bundles in the Mercy Hospital.

The study results showed that the use of the SwabCap disinfecting cap for needle-free connectors successfully reduced central line–associated bloodstream infections (HA-CLABSI) and blood culture contamination (BCC) in hematology-oncology patients.

Browse 8 Market Data Tables and 12 Figures spread through 90 Pages and in-depth TOC on 'Disinfecting Cap Market'- U.S. Forecast to 2027, by Application (Central Venous Line, Peripheral IV Catheters and Others), and by End User (Hospital and Clinics, Ambulatory/ Outpatient Surgical Centers, and Others).

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/us-disinfecting-cap-market-3630

Similarly, in November 2019, ICU Medical, Inc. acquired Pursuit Vascular, Inc., a medical device company engaged in the development of innovative catheter disinfecting products and technologies to reduce the risk of bloodstream infections associated with catheters.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3630

For instance, according to a study published in 2017 by 3M, Curos disinfecting cap achieved 99.99% efficiency in reducing 6 microbes (Staphylococcus auras, Staphylococcus epidermidis, Escherichia coli, CANDIDA albicans, Pseudomonas aeruginosa, and Candida glabarta), which are associated with CLABSI.

Among end user, the hospitals and clinics segment held a major market share in 2019. Hospitals are major end users of disinfecting caps as these caps are majorly used to protect catheters and I.V. access points from contamination risk

The companies operating in the U.S. disinfecting cap market include ICU Medical, C.R. Bard, Becton, Dickinson and Company, 3M, Merit Medical Systems, and other prominent players.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3630

Contact
Mr. Shah
sales@coherentmarketinsights.com
+1-206-701-6702
End
Source: » Follow
Email:***@coherentmarketinsights.com
Posted By:***@coherentmarketinsights.com Email Verified
Tags:Healthcare
Industry:Health
Location:Seattle - Washington - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Coherent Market Insights News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share